The Kingsville-based cultivator reported net revenue of $7.4 million for the year ended March 31, 2026, down from $8.9 million the previous year. CEO Jamie D'Alimonte described the period as a year of transition, noting that while sales volumes moderated, the company successfully shifted its focus toward premium cultivars with stronger long-term pricing potential. International sales now account for approximately 50% of total flower volume, a key pillar in the firm’s strategy to bypass volatile domestic wholesale conditions.
Greenway Greenhouse Reports Pivot Toward International Cannabis Markets
Greenway Greenhouse Cannabis Corporation achieved a 21% increase in its average selling price during fiscal 2026, reaching $1.60 per gram, even as the company navigated a transition toward higher-value international medical markets and recorded a one-time inventory impairment of $1.1 million.
Operational discipline remained a priority, with the company generating $1.1 million in Adjusted EBITDA, marking its second consecutive year of positive results. The bottom line was impacted by a $2.6 million net loss, which included a non-cash charge related to legacy inventory that no longer aligns with current production goals. Despite this, the company strengthened its financial position, ending the year with a positive working capital balance of $4.5 million. Looking toward fiscal 2027, management intends to maintain its focus on international export partnerships and operational efficiency to drive sustainable growth.
Comments (0)
No comments yet. Be the first!